-
 Cord Blood America Inc. - CBAI
Just bought in Cord Blood America Inc. - CBAI. Looks like great potential.
-
 Re: Cord Blood America Inc. - CBAI
Stem Cell Stock.
Breakout yesterday!
-
Re: Cord Blood America Inc. - CBAI
Getting ready to move back up. Buy volume is increasing a lot!
-
Re: Cord Blood America Inc. - CBAI
Yes this one along with ACTC are going to REALLY explode since they both have a low float and are solid companies. ACTC has many important licenses and patents and CBAI has a great PR machine and a big time investor in Blue Cross.
-
 Re: Cord Blood America Inc. - CBAI
LSTM - Same Branch - Just bought - looks like more potential than CBAI
-
Re: Cord Blood America Inc. - CBAI
Cord Blood America, Inc. (CBAI.OB) Substantially Reduces Long Term Debt
Yesterday, Cord Blood America announced that $1 million of long term debt has been eliminated between January 1, 2009 and February 12, 2009. The company previously expressed its desire to reduce debt and strengthen its balance sheet in press releases and CEO interviews. Cord Blood America plans to continue its effort to further reduce debt throughout 2009.
The company’s CEO Matthew Schissler stated, “It’s a start. De-levering our balance sheet coupled with strategic growth and acquisitions are the primary goals for 2009. I’m certain shareholders would agree that removing debts will help put the company in a strong position for long term growth in the stem cell industry.”
-
Re: Cord Blood America Inc. - CBAI
I added at .0139 guys and this is a SURE winner since they have solid support and a great PR machine as they really care about their investors. This looks to go to around .05 once Obama and Congress start talking stem cells since it has already tested .025.
-
Re: Cord Blood America Inc. - CBAI
Cord Blood America, Inc. (CBAI.OB) is Focused on Becoming the Leader in Stem Cell Preservation
Cord Blood America has made it a priority to be the most respected stem cell preservation company in the world. The company seeks to achieve its goal by educating expectant parents, families with a history of disease, critically ill patients, and all others who wish to learn about this life saving opportunity.
Founded in 2002, Cord Partners, a subsidiary of Cord Blood America, has established itself as a platinum standard national competitor in the umbilical cord blood storage industry. Cord Partners was founded by Matthew L. Schissler, Chairman and CEO, Stephanie Schissler, former President & COO, and Laura Fitzpatrick, former Vice President of Strategic Relations.
Cord Blood America, Inc. was founded on one, simple principle: The families who seek stem cell preservation should never have to work to achieve this. Cord Blood America has bundled services such as medical kit preparation, medical courier arrangement, 24/7 customer service, easy enrollment, and one price for all services, offering the highest quality stem cell preservation available.
-
Re: Cord Blood America Inc. - CBAI
Cord Blood America Inc. (CBAI.OB): President Obama Guarantees Stem Cell Work
Cord Blood America’s focus is on preserving stem cells, taken from the blood remaining in the umbilical cord and placenta after birth, to combat life-threatening illnesses. Research and development has shown that cord blood stem cells have tremendous future value for treating blood disorders and genetic diseases because the concordant stem cells in blood can be developed to match a patient’s own blood.
Earlier this month President Obama guaranteed lawmakers that he will sign an executive order overturning President Bush’s embryonic stem cell research policy. Mr. Obama said the executive order would be coordinated with Congress on timing and that it’s important Congress also pass a law codifying his order so that a future president can’t easily reverse the policy.
Dr. Neil Theise, an adult stem cell researcher and professor of pathology and medicine at the Beth Israel Medical Center of Albert Einstein College of Medicine in New York, said that a lifting of the embryonic stem cell research ban would “lift the need for political opposition to adult stem cell research, as well” and have benefits across the board for all forms of stem cell research.
By encouraging and supporting the research of stem cell science, more discoveries will be made and more diseases will become curable. As families see the increasing immediate benefits of preserving their children’s stem cells, more will demand Cord Blood America’s life-saving services. With a whole new medical field just beginning to be explored, the possibilities are endless.
-
Re: Cord Blood America Inc. - CBAI
Cord Blood America, Inc. (CBAI.OB) Provides Details of Shareholder Meeting in Analyst Interview
Friday, Cord Blood America announced that founder and CEO Matthew Schissler provided details of the company’s special shareholder meeting in March. The details were given in an interview with analyst Francis Gaskins. The complete interview can be heard at: http://www.stoxrox.com/cbai-2-18-09-e.mp3
In the interview, Mr. Schissler explained why the company would like to increase its authorized shares. He said that authorized is “vastly different from outstanding” and the company has no commitments or understandings for the issuance of additional outstanding shares other than those currently on file at the SEC.
“Our goal is to be ahead of the game. We want to grow the Company into a global leader in the storage of stem cells and that includes the ability to act and react quickly. We also want to benefit from what we believe will be greatly increased research in this sector. This lets us control our destiny,” Mr. Schissler stated.
When asked why Cord Blood America is looking for such a large increase in authorized shares, the CEO replied, “This is a time-consuming, costly process and we only want to do it once in the Company’s history.”
|
Checking For Related Data... |
View Profile
View Forum Posts
Private Message
Reply With Quote
Visit Homepage
Posting Permissions
Bookmarks